13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuroprogression
Neuroprogression denotes the gradual deterioration of symptoms and cognitive functions seen in various neurological disorders like Alzheimer's, Parkinson's, and multiple sclerosis (MS). It encapsulates the evolving structural and functional alterations within the brain, ultimately resulting in escalating disability and impairment in daily life. This phenomenon encompasses the progressive accumulation of neuronal damage, inflammation, and the loss of neural connections. In Alzheimer's, neuroprogression entails the progressive accumulation of amyloid plaques and tau protein tangles, leading to nerve cell degeneration and cognitive decline. Similarly, Parkinson's disease manifests as the gradual loss of dopamine-producing neurons in the substantia nigra, worsening motor symptoms like tremors and stiffness. In MS, immune attacks on the myelin sheath lead to scar tissue formation and progressive neurological dysfunction, including muscle weakness and coordination problems. Understanding neuroprogression is pivotal for devising effective treatments to slow or halt disease progression. Researchers explore various strategies, from targeted medications to lifestyle interventions and neurorehabilitation techniques, to mitigate neuroprogressive processes and enhance patients' quality of life. Early diagnosis, ongoing monitoring, and multidisciplinary care are vital for managing the complex needs of individuals with progressive neurological conditions.
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : Nanoparticles passing the blood brain barrier to treat cancer, infection, and more
Thomas J Webster, Brown University, United States
Title : Transcranial painless neurorehabilitation scalp acupuncture electrical stimulation for neuroregulation of autism spectrum disorder
Zhenhuan Liu, Guangzhou University Chinese Medicine, China
Title : Effects of prenatal androgen exposure on Purkinje cell morphology in the cerebellum of female rats
Kiran Ghotra, Lake Erie College of Osteopathic Medicine, United States